15-Year watch begins for revolutionary cancer Treatment's Long-Term effects
NCT ID NCT06701201
Summary
This study will monitor 60 people for 15 years after they received an experimental cancer treatment called SynKIR CAR T-cell therapy. The main goal is to check for any long-term side effects and see how well the treatment continues to work over time. No new treatment is given in this study—it's purely for long-term observation of people who already received the therapy in a previous trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Colorado Blood Cancer Institute, part of Sarah Cannon Research Institute
Denver, Colorado, 80218, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
-
Winship Cancer Institute of Emory University
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.